|
MOAP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.8897000003969E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.86009999994619E-06 |
| Normal-vs-Stage2 |
4.985600E-01 |
| Normal-vs-Stage3 |
2.23919999986499E-07 |
| Normal-vs-Stage4 |
5.94520000007925E-07 |
| Stage1-vs-Stage2 |
1.775530E-02 |
| Stage1-vs-Stage3 |
1.323980E-01 |
| Stage1-vs-Stage4 |
6.893700E-02 |
| Stage2-vs-Stage3 |
2.098800E-03 |
| Stage2-vs-Stage4 |
1.455030E-03 |
| Stage3-vs-Stage4 |
5.318000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.0686999951659E-08 |
| Normal-vs-AfricanAmerican |
7.983800E-01 |
| Normal-vs-Asian |
1.298700E-03 |
| Caucasian-vs-AfricanAmerican |
6.664800E-03 |
| Caucasian-vs-Asian |
4.832200E-01 |
| AfricanAmerican-vs-Asian |
6.637600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.06360000041006E-07 |
| Normal-vs-Female |
2.39250000000357E-06 |
| Male-vs-Female |
2.431800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.70380000000348E-06 |
| Normal-vs-Age(41-60Yrs) |
1.70442999999354E-05 |
| Normal-vs-Age(61-80Yrs) |
3.808000E-04 |
| Normal-vs-Age(81-100Yrs) |
1.391200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.856600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.206200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.189200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.904400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.615600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.294800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.12590000000967E-06 |
| Classical-VS-Follicular |
5.98609999999944E-05 |
| Classical-VS-Other |
4.762000E-01 |
| Classical-VS-Normal |
2.03960000000336E-07 |
| Tall-VS-Follicular |
2.48320253248835E-11 |
| Tall-VS-Other |
1.406040E-01 |
| Tall-VS-Normal |
2.02016181560793E-12 |
| Follicular-VS-Other |
6.810300E-02 |
| Follicular-VS-Normal |
9.670200E-01 |
| Other-VS-Normal |
2.817600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.847100E-04 |
| Normal-vs-N1 |
1.87589999089965E-09 |
| N0-vs-N1 |
3.207100E-04 |
|
|
